LC
ISEE

Lindbrook Capital’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Lindbrook Capital’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-409
Closed -$16.1K – 2873
2023
Q2 		$16.1K Sell
409
-15,932
-97% -$562K ﹤0.01% 1206
2023
Q1 		$398K Sell
16,341
-102
-0.6% -$2.23K 0.05% 203
2022
Q4 		$352K Buy
16,443
+309
+2% +$6.59K 0.04% 221
2022
Q3 		$289K Buy
16,134
+44
+0.3% +$578 0.05% 215
2022
Q2 		$155K Buy
16,090
+115
+0.7% +$1.44K 0.03% 345
2022
Q1 		$269K Hold
15,975
– – 0.04% 238
2021
Q4 		$267K Buy
15,975
+15,175
+1,897% +$249K 0.04% 244
2021
Q3 		$13K Buy
+800
New +$8.71K ﹤0.01% 911
2020
Q3 		– Sell
-2,000
Closed -$10K – 1875
2020
Q2 		$10K Buy
+2,000
New +$8.33K ﹤0.01% 845
2020
Q1 		– Sell
-3,000
Closed -$26K – 1894
2019
Q4 		$26K Buy
+3,000
New +$10.7K 0.01% 651

Lindbrook Capital's ISEE Position: Q3 2023 in Review

Lindbrook Capital sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 409 shares — an estimated $16.1K sold.

Lindbrook Capital first reported a position in ISEE in Q4 2019 and held it in 10 quarters. The position peaked at $398K in Q1 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • Lindbrook Capital reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Lindbrook Capital sold 409 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $16.1K.
  • Lindbrook Capital first reported a position in IVERIC bio, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Lindbrook Capital's IVERIC bio, Inc. Common Stock position peaked at $398K in Q1 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Lindbrook Capital's 13F filing for Q3 2023, filed 25 Oct 2023.